Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
US10087232B2 · kind B2 · utility
1Cited by
3References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 6, 2014 |
| Grant date | Oct 2, 2018 |
| Priority date | — |
| Expiry date | Jul 4, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a TNF Alpha associated medical condition selected from the group consisting of obesity, metabolic syndrome, diabetes and a liver disease or disorder is provided. The method comprising enterally administering to a subject in need thereof a therapeutically effective amount of plant cells expressing a TNF Alpha polypeptide inhibitor, thereby treating the TNF Alpha associated medical condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.